We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$73.5M
Cap. Flow
-$66.1M
Cap. Flow %
-27.19%
Top 10 Hldgs %
48.94%
Holding
62
New
17
Increased
8
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$9.14M
2
HUM icon
Humana
HUM
+$8.85M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.43M
4
VTRS icon
Viatris
VTRS
+$6.68M
5
CERS icon
Cerus
CERS
+$6.23M

Top Sells

Rank Stock Value
1
HSIC icon
Henry Schein
HSIC
+$27.7M
2
PDCO
Patterson Companies, Inc.
PDCO
+$12.4M
3
MSON
Misonix Inc
MSON
+$10.1M
4
PRGO icon
Perrigo
PRGO
+$10.1M
5
UTHR icon
United Therapeutics
UTHR
+$9.82M

Sector Composition

Rank Sector Weight
1 Healthcare 84.43%
2 Consumer Staples 3.88%
3 Consumer Discretionary 2.26%
4 Materials 1.99%
5 Technology 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDNT icon
26
RadNet
RDNT
$4.98B
$3.31M 1.36%
110,000
-80,000
-42% -$2.36M
UTHR icon
27
United Therapeutics
UTHR
$26.1B
$3.24M 1.33%
15,000
-50,000
-77% -$9.82M
JAZZ icon
28
Jazz Pharmaceuticals
JAZZ
$16.1B
$3.19M 1.31%
+25,000
New +$3.29M
INMD icon
29
InMode
INMD
$871M
$3.18M 1.31%
+45,000
New +$3.61M
PHR icon
30
Phreesia
PHR
$689M
$3.13M 1.28%
75,000
– –
AHCO icon
31
AdaptHealth
AHCO
$1.47B
$3.06M 1.26%
125,000
-50,000
-29% -$1.17M
PDCO
32
DELISTED
Patterson Companies, Inc.
PDCO
$2.94M 1.21%
100,000
-395,000
-80% -$12.4M
HSIC icon
33
Henry Schein
HSIC
$9.78B
$2.87M 1.18%
37,000
-363,000
-91% -$27.7M
XBI icon
34
State Street SPDR S&P Biotech ETF
XBI
$10B
$2.8M 1.15%
+25,000
New +$3.02M
TRLV
35
Trulieve Cannabis Corp
TRLV
$1.55B
$2.21M 0.91%
+85,000
New +$2.21M
ITGR icon
36
Integer Holdings
ITGR
$3.39B
$2.14M 0.88%
25,000
-100,000
-80% -$8.73M
CI icon
37
Cigna
CI
$78.4B
$1.84M 0.76%
+8,000
New +$1.7M
SLGC
38
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.75M 0.72%
150,000
– –
TDOC icon
39
PUT
Teladoc Health
TDOC
$1.66B
$584K 0.24%
+250
New +$29.9K
UNH icon
40
UnitedHealth
UNH
$382B
$502K 0.21%
+1,000
New +$453K
OEF icon
41
PUT
iShares S&P 100 ETF
OEF
$19.5B
$425K 0.17%
+1,000
New +$212K
PRGO icon
42
Perrigo
PRGO
$1.44B
$389K 0.16%
10,000
-240,000
-96% -$10.1M
SLGCW
43
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$67K 0.03%
20,000
– –
VTRS icon
44
CALL
Viatris
VTRS
$20.8B
$60K 0.02%
10,000
+5,000
+100% +$66.8K
RIGL icon
45
CALL
Rigel Pharmaceuticals
RIGL
$723M
$14K 0.01%
571
+71
+14% +$2.14K
ARKG icon
46
PUT
ARK Genomic Revolution ETF
ARKG
$1.53B
– –
-750
Closed -$735K
BMRN icon
47
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
– –
-1,500
Closed -$23K
HOLX
48
CALL
DELISTED
Hologic
HOLX
– –
-1,000
Closed -$420K
HSIC icon
49
CALL
Henry Schein
HSIC
$9.78B
– –
-1,500
Closed -$405K
ICUI icon
50
ICU Medical
ICUI
$4.16B
– –
-35,000
Closed -$8.17M
1
2
3

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Tamarack Advisers held 62 positions worth $243M, down 23% from $317M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Tamarack Advisers withdrew a net $66.1M in Q4 2021, closing 14 positions and reducing 19 holdings. Its most notable exit was Misonix Inc, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Tamarack Advisers opened a new position in Humana worth $9.28M.

  • Tamarack Advisers's largest Q4 2021 buy was Humana: 20,000 shares worth $9.28M.
  • Tamarack Advisers added most to Tenet Healthcare in Q4 2021, an estimated $9.14M increase.
  • Tamarack Advisers's biggest Q4 2021 reduction was Henry Schein, cutting an estimated $27.7M.
  • Tamarack Advisers fully exited Misonix Inc in Q4 2021, selling an estimated $10.1M.
  • Tamarack Advisers's ten largest holdings make up 49% of its $243M portfolio in Q4 2021.
  • Tamarack Advisers opened 17 new positions and closed 14 in Q4 2021.
  • Tamarack Advisers's portfolio value fell 23% quarter-over-quarter to $243M.

Based on Tamarack Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.